Valbenazine CAS:1025504-45-3

Valbenazine（NBI-98854 and MT-5199)is a potent and selective VMAT2 inhibitor. NBI-98854 is effective in regulating the levels of dopamine release during nerve communication,while at the same time having minimal impact on the other monoamines.NBI-98854 is promising agent for the treatment of tardive dyskinesia.NBI-98854 significantly improved tardive dyskinesia and was well tolerated in patients.These results support the phase 3 clinical trials of NBI-98854 now underway.

msds---Valbenazine